148 related articles for article (PubMed ID: 6517929)
1. Complement channels in membranes: inhibition with a monoclonal antibody to a neoantigen of polymerized C9.
Dalmasso AP; Benson BA; Falk RJ
Biochem Biophys Res Commun; 1984 Dec; 125(3):1013-9. PubMed ID: 6517929
[TBL] [Abstract][Full Text] [Related]
2. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
[TBL] [Abstract][Full Text] [Related]
3. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
Ramm LE; Whitlow MB; Mayer MM
J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
[TBL] [Abstract][Full Text] [Related]
4. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
Zalman LS; Müller-Eberhard HJ
Mol Immunol; 1990 Jun; 27(6):533-7. PubMed ID: 1696352
[TBL] [Abstract][Full Text] [Related]
5. Membrane attack complex of complement in dermatitis herpetiformis.
Dahl MV; Falk RJ; Carpenter R; Michael AF
Arch Dermatol; 1985 Jan; 121(1):70-2. PubMed ID: 3881089
[TBL] [Abstract][Full Text] [Related]
6. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
7. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
Bhakdi S; Tranum-Jensen J
J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
[TBL] [Abstract][Full Text] [Related]
8. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of complement-induced [14C]sucrose release by intracellular and extracellular monoclonal antibodies to C9: evidence that C9 is a transmembrane protein.
Morgan BP; Luzio JP; Campbell AK
Biochem Biophys Res Commun; 1984 Jan; 118(2):616-22. PubMed ID: 6704099
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
Zalman LS; Wood LM; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
[TBL] [Abstract][Full Text] [Related]
11. The membrane attack complex of complement: lipid insertion of tubular and nontubular polymerized C9.
Amiguet P; Brunner J; Tschopp J
Biochemistry; 1985 Dec; 24(25):7328-34. PubMed ID: 4084584
[TBL] [Abstract][Full Text] [Related]
12. Using polymerized C9 to produce a monoclonal antibody against a neoantigen of the human terminal complement complex.
Kusunoki Y; Takekoshi Y; Nagasawa S
J Pharmacobiodyn; 1990 Jul; 13(7):454-60. PubMed ID: 2290128
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement.
Hugo F; Jenne D; Bhakdi S
Biosci Rep; 1985 Aug; 5(8):649-58. PubMed ID: 2415178
[TBL] [Abstract][Full Text] [Related]
14. Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.
Martin DE; Chiu FJ; Gigli I; Müller-Eberhard HJ
J Clin Invest; 1987 Jul; 80(1):226-33. PubMed ID: 3597774
[TBL] [Abstract][Full Text] [Related]
15. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
Tschopp J; Mollnes TE
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of activation of the human terminal complement pathway by ELISA.
Sanders ME; Schmetz MA; Hammer CH; Frank MM; Joiner KA
J Immunol Methods; 1985 Dec; 85(2):245-56. PubMed ID: 2416846
[TBL] [Abstract][Full Text] [Related]
17. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
Tschopp J; Podack ER; Müller-Eberhard HJ
J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819
[TBL] [Abstract][Full Text] [Related]
18. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructure of the membrane attack complex of complement. Heterogeneity of the complex caused by different degree of C9 polymerization.
Tschopp J
J Biol Chem; 1984 Jun; 259(12):7857-63. PubMed ID: 6736027
[TBL] [Abstract][Full Text] [Related]
20. Restriction of cell lysis by homologous complement: I. An analysis of membrane attack complex formation on target membranes.
Houle JJ; Hoffmann EM; Esser AF
Blood; 1988 Feb; 71(2):280-6. PubMed ID: 3337896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
